CARVER JENNIFER 4
4 · LA JOLLA PHARMACEUTICAL CO · Filed Feb 19, 2019
Insider Transaction Report
Form 4
CARVER JENNIFER
Sr. Vice President, Operations
Transactions
- Award
Stock Option (Right to Buy)
2019-02-15+230→ 230 totalExercise: $6.23Exp: 2029-02-15→ Common Stock (230 underlying) - Award
Common Stock
2019-02-15$5.30/sh+230$1,219→ 13,819 total
Footnotes (2)
- [F1]These shares were acquired on 02/15/2019 through the La Jolla Pharmaceutical Company 2018 Employee Stock Purchase Plan in a transaction that was exempt under both Rule 16b-3(d) and Rule 16b-3(c).
- [F2]The stock option vests and becomes exercisable with respect to 25% of the underlying shares on the one-year anniversary of grant date and then vests and becomes exercisable ratably on a monthly basis over the next three years.